组织损伤及器官移植
肾脏疾病
肝硬化是一种由瘢痕损害肝脏的疾病。这种情况可能会阻碍血液流经肝脏,影响其功能。由于肝脏在体内参与多种功能,如消化、凝血、分解酒精和药物以及储存维生素和矿物质,肝硬化可能会导致严重的健康并发症。
间充质干细胞的再生特性正在被探索用于治疗肝硬化。它们已被用于小鼠的瘢痕肝组织再生。
临床试验课题 | 临床试验编号 |
---|---|
Can patients with liver cirrhosis be safely and effectively treated via intravenous administration of umbilical mesenchymal stem cells? |
NCT01573923
Alliancells Bioscience Corporation Limited, China |
Using umbilical cord mesenchymal stem cells transplants to treat patients with damaged livers due to cirrhosis |
NCT01342250
Shenzhen Beike Bio-Technology Co., Ltd, China |
Multicenter study looking at the safety and effectiveness of using umbilical cord mesenchymal stem cell transfusions to treat liver cirrhosis. |
NCT03529136
Jinan Hospital for Infectious Diseases |
Is infusing umbilical cord mesenchymal stem cells through the hepatic artery an effective method for treating liver cirrhosis? |
NCT01224327
Qingdao University |
Evaluating the safety and effectiveness of administering umbilical cord mesenchymal stem cells via the hepatic artery to treat patients with hepatitis B-related liver cirrhosis. |
NCT01728727
Fourth Military Medical University, China |
Looking at using mesenchymal stem cells (derived from bone marrow and umbilical cord tissue) to treat liver cirrhosis. |
NCT01877759
Chaitanya Hospital, Pune, India |
Can umbilical mesenchymal stem cells improve the outcome of liver transplants? |
NCT01690247
Beijing 302 Hospital, China |
Using the umbilical cord stem cells (19#iSCLife®-LC) to treat liver cirrhosis caused by hepatitis B. |
NCT03826433
Xiangya Hospital Central South University, China |